Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy

Launched by QILU HOSPITAL OF SHANDONG UNIVERSITY · Nov 19, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at two types of surgery for patients with esophagus cancer: minimally invasive esophagectomy and open esophagectomy. The goal is to see which surgery leads to better long-term survival and quality of life for patients. Researchers will study how these surgeries affect patients differently based on the type of esophageal cancer they have and how advanced it is. They will also consider other factors that may influence survival after surgery.

To be eligible for this trial, patients must have undergone surgery for esophageal cancer at a specific hospital between 2013 and 2021, and their cancer type must be confirmed as certain types of malignant tumors. Participants can expect to contribute to important research that may help in choosing the best surgical methods for future patients. It’s important to know that the trial is not yet recruiting, meaning they haven’t started enrolling participants yet.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients who had undergone esophageal cancer resection at the Department of Thoracic Surgery, Qilu Hospital, Shandong University, between 2013 and 2021, with pathology results confirming esophageal squamous carcinoma, adenocarcinoma, or other malignant tumors.
• • 2. The surgery was successfully completed, the patient was safely discharged from the hospital, the postoperative follow-up was successful, and if the follow-up patient died, his or her death was due to natural causes.
• Exclusion Criteria:
• • Perioperative patient deaths, pathologic findings other than those listed above, loss of visits, and postoperative unnatural deaths.